Drug-labels.com

PMS-Calcitriol: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
0.25 mcg, 0.5 mcg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - PMS-Calcitriol

ABOUT THIS MEDICATION

What the medication is used for:

pms-CALCITRIOL is indicated in the management of

  • Calcium deficiency (hypocalcemia) and bone disease in patients with chronic renal failure undergoing dialysis
  • Calcium deficiency (hypocalcemia) in patients with hypoparathyroidism (underactive parathyroid glands).
  • Rickets (type of bone disease).

What it does:

pms-CALCITRIOL helps patients with kidney or bone disease (eg. rickets) who cannot make enough of the active form of vitamin D in the body to meet their needs. pms-CALCITRIOL supplies this form of vitamin D which the body can use to meet requirements.

When it should not be used:

  • If you are allergic to the medicinal ingredient calcitriol, vitamin D, other vitamin D products or other forms of vitamin D or to any of the nonmedicinal ingredients in this formulation (see What the non-medicinal ingredients are).
  • If you have hypercalcemia (high levels of calciumin the blood).

What the medicinal ingredient is:

calcitriol

What the important non-medicinal ingredients are:

butylhydroxyanisole, butylhydroxytoluene, medium-chain triglycerides, gelatin, glycerin, sorbitol solution, FD&C yellow #6, FD & C Red #3, titaniumdioxide, shellac, iron oxide black, and propylene glycol.

What dosage forms it comes in:

Capsules 0.25 mcg: Orange colored, oval shaped opaque soft gelatin capsule printed '673' in black and containing clear oily liquid.

Capsules 0.5 mcg: Orange colored, oblong shaped opaque soft gelatin capsule printed '674' in black and containing clear oily liquid.

WARNINGS AND PRECAUTIONS

BEFORE you use pms-CALCITRIOL talk to your doctor or pharmacist if:

  • you are allergic to vitamin D or other forms of vitamin D products or to any ingredient of pms-CALCITRIOL.
  • you have a history of kidney disease.
  • you are undergoing dialysis.
  • you have a history of heart disease.
  • you are using cardiac glycosides (eg.digitalis).
  • you are pregnant or planning to become pregnant during treatment.

  • you are breastfeeding or planning to breastfeed. pms-CALCITRIOL may be released in human breast milk. Discuss with your doctor.
  • you are taking any other drugs including non-
  • prescription drugs, other vitamin D products, or other forms of vitamin D or any other vitamins or supplements.

INTERACTIONS WITH THIS MEDICATION

Drugs that may interact with pms-CALCITRIOL include: digitalis, bile acid sequestrants (including cholestyramine and sevelamer) and mineral oil, anticonvulsants (e.g. phenytoin, phenobarbital), calcium supplements, corticosteroids, ketoconazole, magnesium-containing drugs (e.g. some antacids), thiazides.

PROPER USE OF THIS MEDICATION

The effectiveness of pms-CALCITRIOL therapy is based on the assumption that each patient is receiving an adequate daily intake of calcium.

To ensure that you receive an adequate daily intake of calcium, your doctor may either prescribe a calcium supplement or instruct appropriate dietary measures. Your doctor may monitor your blood levels of calcium and phosphorus.

Be sure to drink plenty of fluids to maintain good hydration, important during pms-CALCITRIOL treatment.

Usual adult dose:

Dosage is based on your medical condition and response to therapy. Your doctor may start you on a low dose and adjust the dose slowly to find the best dose for you. Follow your doctor's directions carefully.

Missed Dose

Take your missed dose as soon as you remember. Skip taking the missed dose if it is almost time for the next scheduled dose. No extra medicine should be taken to make up the missed dose.

Overdose:

In case of drug overdose, contact a health care practitioner, hospital emergency department or regional Poison Control Centre immediately, even if there are no symptoms.

SIDE EFFECTS AND WHAT TO DO ABOUT THEM

The most common side effect of pms-CALCITRIOL is hypercalcemia -high calcium levels in the blood (see Serious Side Effects table below for symptoms). Common side effects include nausea, vomiting, stomach cramps, itching and sleeplessness.

Other side effects include agitation, sleeplessness, lack of feeling, weakness, constipation, upper abdominal pain, redness or itching of the skin, excessive thirst, fever and joint pain. If these side effects become bothersome or persist, contact your doctor.

SERIOUS SIDE FFECTS, HOW OFTEN THEY HAPPEN AND WHAT TO DO ABOUT THEM
Symptom / effectTalk with your doctor or pharmacistStop taking drug and call your doctor or pharmacist
Only if severeIn all cases
Very common

Higher blood calcium levels than normal. Possible symptoms:

Early

symptoms: weakness, headache, drowsiness, nausea, irregular heartbeat,

excessive thirst, vomiting, dry mouth,

constipation, muscle pain, bone pain, metallic taste,

abdominal pain or stomach ache.

Late symptoms:

frequent urination (including

√
needing to urinate at night), excessive thirst, urinary tract infections, anorexia, weight loss, conjunctivitis, inflammation of the pancreas, sensitivity to light, runny nose, itching, feeling feverish, decreased sex drive, too much protein in the urine, high cholesterol, elevated liver function tests, excessive calcium in tissues, high blood pressure, irregular heartbeat, and rarely, loss of contact with reality.
Common

Headache Abdominal pain

  • Rash

Urinary tract infection

√
Uncommon

Decreased appetite

Vomiting

√
Not known

Allergic reactions -Possible symptoms:

hives, difficulty breathing, swelling of your face, lips, tongue, or throat.

√

Difficulty in understanding

Growth

√

retardation

Excessive urination

Calcium deposits on the skin

Weight loss

This is not a complete list of side effects. For any unexpected effects while taking, pms-CALCITRIOL contact your doctor or pharmacist.

HOW TO STORE IT

Capsules should be stored a 15-30°C. Store in the original container. Protect from light and moisture. Keep blister in the outer carton. Keep out of sight and reach of children.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada/adverse-reaction-reporting.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

MORE INFORMATION

If you want more information about pms-CALCITRIOL:

  • Talk to your healthcare professional.
  • Find the full product monograph that is prepared for healthcare professionals and includes this Consumer Information by visiting the Health Canada website (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html) or by calling Pharmascience Inc. at 1-888-550-6060.

Last revised: MAR 13, 2023

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02495899

Revision date stated in the text: March 13, 2023

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for PMS-Calcitriol

Rx or OTC
Prescription (Rx)?
DIN 02495899, 02495902
Schedule(s) PRESCRIPTION
Active ingredient(s) Calcitriol
Dosage form(s) Capsule
Route(s) of administration Oral
Drug class (WHO ATC)
  1. A Alimentary tract and metabolism drugs
    1. A11 Vitamins
      1. A11C Vitamin A and D, incl. combinations of the two
        1. A11CC Vitamin D and analogues
          1. A11CC04 Calcitriol
Company PHARMASCIENCE INC
Current status Marketed
Current status date September 30, 2026
Strengths and forms
DIN Strength Dosage form(s) Current status
02495899 0.25 MCG Capsule Marketed September 30, 2026
02495902 0.5 MCG Capsule Marketed September 30, 2026

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 1, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.